Developing a new generation of therapies to protect, restore, and improve vision

Biotechnology

EyeBio

EyeBio's headquarters in London, United Kingdom

David Guyer

Loni da Silva MS RAC

Jonathan Prenner

Anthony P. Adamis

Jonathon Dines

Loni Da Silva

Sarah Milsom

Mike Ross

Andreas Wallnoefer

Kate Bingham

Evelyn Harrison

Srinivas Akkaraju

The Drug Development and Regulatory Team at EyeBio oversees the entire lifecycle of vision therapy products, ensuring they are developed efficiently, meet stringent quality standards, and comply with regulatory requirements. The team integrates expertise from biology, chemistry, clinical development, and global operations to bring innovative vision therapies from the lab to market safely and effectively.

Drug Development and Regulatory Team

The Leadership Team at EyeBio drives the strategic vision and operational execution of the company's mission to advance innovative therapies for vision protection and restoration. Comprised of key executives with diverse expertise in medical, operational, and manufacturing fields, the team collaborates to guide research initiatives, oversee clinical development, and ensure compliance with regulatory standards, all aimed at transforming patient outcomes in eye health.

Leadership Team

The Clinical Operations Team at EyeBio is responsible for planning, executing, and managing clinical trials aimed at developing innovative therapies for eye health. This team ensures compliance with regulatory standards, oversees patient recruitment, and strategizes clinical trial operations to protect, restore, and improve vision.

EyeBio

Org chart

Board & advisors

Teams

Drug Development and Regulatory Team

Leadership Team

Clinical Operations Team

Offices

EyeBio

Org chart

Board & advisors

Teams

Drug Development and Regulatory Team

Leadership Team

Clinical Operations Team

Offices

Related companies